Table I.
Variable | n | % |
---|---|---|
Sex | ||
Male | 239 | 65.1 |
Female | 128 | 34.9 |
Age, years | ||
≤45 | 45 | 12.3 |
45< × ≤60 | 130 | 35.4 |
>60 | 192 | 52.3 |
Adjuvant chemotherapy | ||
No | 93 | 25.3 |
Yes | 180 | 49.0 |
Not available | 94 | 25.6 |
Histological grade and type | ||
Well differentiated | 22 | 6.0 |
Moderately differentiated | 110 | 30.0 |
Poorly differentiated | 173 | 47.1 |
Signet ring cell carcinoma | 48 | 13.1 |
Mucinous adenocarcinoma | 13 | 3.5 |
Undifferentiated carcinoma | 1 | 0.3 |
T-stagea | ||
T1 | 19 | 5.2 |
T2 | 49 | 13.4 |
T3 | 183 | 49.9 |
T4 | 116 | 31.6 |
N-stagea | ||
N0 | 78 | 21.3 |
N1 | 84 | 22.9 |
N2 | 100 | 27.2 |
N3 | 105 | 28.6 |
TNM stagea | ||
II | 177 | 48.2 |
III | 190 | 51.8 |
Lymphatic invasion | ||
Absent | 121 | 33 |
Present | 246 | 67 |
Venous invasion | ||
Absent | 283 | 77.1 |
Present | 84 | 22.9 |
Perineural invasion | ||
Absent | 172 | 46.9 |
Present | 195 | 53.1 |
As defined by the American Joint Committee on Cancer 7th edition; TNM, Tumor-Node-Metastasis.